Cite

HARVARD Citation

    Gleicher, S. et al. (2016). Implications of High Rates of Metastatic Prostate Cancer in BRCA2 Mutation Carriers. Prostate. 76 (13), pp. 1135-1145. [Online]. 
  
Back to record